PolyPid Ltd. Ordinary Shares — Rendiconto Finanziario Trimestrale (NASDAQ:PYPD) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Market Capitalization 82.65 M
Employee 75
Founded 2008
CEO N/A
Website www.polypid.com
Headquarter Israel
FIGI UNKNOWN
Industry Technology

Ricavi totali

Utile netto

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

82.65 M Capitalizzazione di mercato

Notizie

PolyPid presenterà dati farmacocinetici di D-PLEX100 all’ESCMID Global

PolyPid receives $4.3M FDA fee waiver for D-PLEX100 application

PolyPid al Citizens Life Sciences: Mosse Strategiche ed Espansione

PolyPid at Citizens Life Sciences: Strategic Moves and Market Expansion

McDonald’s, Cisco, Shopify, and more set to report earnings Wednesday

PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript

Le azioni PolyPid salgono dopo il supporto della FDA per la NDA di D-PLEX100

PolyPid stock rises after FDA supports NDA submission for D-PLEX100

PolyPid riceve supporto FDA per la presentazione NDA di D-PLEX100

PolyPid receives FDA support for D-PLEX100 NDA submission

Rating del titolo PolyPid confermato a Market Outperform da Citizens

PolyPid stock rating reiterated at Market Outperform by Citizens